Press Release Press Release Section
Business
Press Release Press Release Latest Valoir Research Finds Fear of Messing Up AI Adoption is Eroding HR’s Confidence
Press Release Elion Therapeutics Expands Pipeline with Exclusive Global License to Inhaled Antifungal for Immunocompromised Patients
Press Release Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
Press Release Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer
Press Release OutSolve Releases New Report Examining the Surge in I-9 Enforcement and Its Impact on Employers
Press Release DMC Global to Report Third Quarter Financial Results on October 27, 2026
Press Release Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
Press Release Orvida Pharma Announces FDA Acceptance of KM-023 (ontivatrep) into Rare Disease Evidence Principles Process for Olmsted Syndrome
Press Release Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
Press Release Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington’s Disease Franchise
Press Release SOPRIS TECHNOLOGIES Appoints Global Technology Executive Hari Haran to Board of Directors
Press Release